Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma

National Medical Journal of China

Volumn 87, Issue 3, 2007, Pages 150-154

  Xue, Li Yan ^a   Ren, Li Qun ^b   Luo, Wei ^b   Guan, Xiang Jun ^b   Zou, Shuang Mei ^b   Zheng, Shan ^b   Bi, Rui ^b   Xie, Yong Qiang ^b   He, Zu Gen ^b   Lü, Ning ^b  

^a CANCER HOSPITAL   (China)

^b NONE

Author keywords

Apoptosis; Esophageal neoplasms; Immunohistochemistry; Pathology

Indexed keywords

CASPASE 8; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; MUTANT PROTEIN; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BASAL CELL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE MARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADULT; AGED; ANTIGENS, CD95; CARCINOMA, SQUAMOUS CELL; CASPASE 8; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTANT PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33947106000     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nagata S. Apoptosis by death factor. Cell, 1997, 88: 355-365.
2. Nishioka H, Hiasa Y, Hayashi I, et al. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology, 1993, 50: 426-429.
3. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998, 4: 844-847.
4. Hao XP, Pretlow TG, Rao JS, et al. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res, 2001, 61: 8085-8088.
5. Gratas C, Tohma Y, Barnas C, et al. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res, 1998, 58: 2057-2062.
6. Kase S, Osaki M, Adachi H, et al. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. Int J Oncol, 2002, 20: 291-297.
7. Shibakita M, Tachibana M, Dhar DK, et al. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. Clin Cancer Res, 1999, 5: 2464-2469.
8. Shibakita M, Tachibana M, Dhar DK, et al. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression. Clin Cancer Res, 2000, 6: 4755-4759.
9. Shin EC, Shin JS, Park JH, et al. Expression of Fas-related genes in human hepatocellular carcinomas. Cancer Lett, 1998, 134: 155-162.
10. Su H, Hu N, Shih J, et al. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res, 2003, 63: 3872-3876.
11. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, et al. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res, 2000, 60: 4315-4319.
12. Pingoud-Meier C, Lang D, Janss AJ, et al. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res, 2003, 9: 6401-6409.
13. Zuzak TJ, Steinhoff DF, Sutton LN, et al. Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/ medulloblastoma. Eur J Cancer, 2002, 38: 83-91.
14. Vakkala M, Paakko P, Soini Y. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer, 1999, 81: 592-599.
15. Turunen N, Paakko P, Soini Y. Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax. Histol Histopathol, 2000, 15: 53-60.
16. Virkajarvi N, Paakko P, Soini Y. Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology, 1998, 33: 432-439.
17. Yasuda M, Kuwano H, Watanabe M, et al. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Br J Cancer, 2000, 83: 1033-1038.
18. Tian D, Feng Z, Hanley NM, et al. Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization. Int J Cancer, 1998, 78: 568-575.
19. Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol, 1995, 19: 1418-1422.